Author:
Jachimowski Piotr,Ziarkiewicz Mateusz,Ciulkiewicz Łukasz,Ziarkiewicz-Wróblewska Bogna,Legatowicz-Koprowska Marta,Jamroziak Krzysztof
Reference18 articles.
1. Waldenstr�m macroglobulinemia: 2021 update on diagnosis, risk stratification, and management;M A Gertz;Am J Hematol,2021
2. Updates in prognostication and treatment of Waldenstr�m's macroglobulinemia;P Advani;Hematol Oncol Stem Cell Ther,2019
3. Cutaneous amyloidosis as the first presentation of Waldenstrom macroglobulinemia;R Rafiei;Caspian J Intern Med,2020
4. A Focus on Waldenstr�m Macroglobulinemia and AL Amyloidosis;R Lu;J Adv Pract Oncol,2022
5. IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features;S Sidana;Leukemia,2019